These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 17979800)

  • 21. Sphingosine kinase/sphingosine 1-phosphate signaling in cancer therapeutics and drug resistance.
    Selvam SP; Ogretmen B
    Handb Exp Pharmacol; 2013; (216):3-27. PubMed ID: 23563649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of bioactive sphingolipids in physiology and pathology.
    Gomez-Larrauri A; Presa N; Dominguez-Herrera A; Ouro A; Trueba M; Gomez-Muñoz A
    Essays Biochem; 2020 Sep; 64(3):579-589. PubMed ID: 32579188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extracellular Sphingosine-1-Phosphate Downstream of EGFR Increases Human Glioblastoma Cell Survival.
    Bassi R; Brambilla S; Tringali C; Giussani P
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Sphingosine kinase 1 and tumor].
    Zhang CX; He HW; Shao RG
    Yao Xue Xue Bao; 2013 Jul; 48(7):971-8. PubMed ID: 24133963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Druggable Sphingolipid Pathways: Experimental Models and Clinical Opportunities.
    Blaho VA
    Adv Exp Med Biol; 2020; 1274():101-135. PubMed ID: 32894509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Roles of sphingosine-1-phosphate (S1P) receptors in malignant behavior of glioma cells. Differential effects of S1P2 on cell migration and invasiveness.
    Young N; Van Brocklyn JR
    Exp Cell Res; 2007 May; 313(8):1615-27. PubMed ID: 17376432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of ceramide synthase 2: tissue distribution, substrate specificity, and inhibition by sphingosine 1-phosphate.
    Laviad EL; Albee L; Pankova-Kholmyansky I; Epstein S; Park H; Merrill AH; Futerman AH
    J Biol Chem; 2008 Feb; 283(9):5677-84. PubMed ID: 18165233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sphingosine-1-phosphate and interleukin-1 independently regulate plasminogen activator inhibitor-1 and urokinase-type plasminogen activator receptor expression in glioblastoma cells: implications for invasiveness.
    Bryan L; Paugh BS; Kapitonov D; Wilczynska KM; Alvarez SM; Singh SK; Milstien S; Spiegel S; Kordula T
    Mol Cancer Res; 2008 Sep; 6(9):1469-77. PubMed ID: 18819934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ceramides promote apoptosis for virus-infected lymphoma cells through induction of ceramide synthases and viral lytic gene expression.
    Dai L; Trillo-Tinoco J; Bai A; Chen Y; Bielawski J; Del Valle L; Smith CD; Ochoa AC; Qin Z; Parsons C
    Oncotarget; 2015 Sep; 6(27):24246-60. PubMed ID: 26327294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sphingosine-1-phosphate stimulates motility and invasiveness of human glioblastoma multiforme cells.
    Van Brocklyn JR; Young N; Roof R
    Cancer Lett; 2003 Sep; 199(1):53-60. PubMed ID: 12963123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ceramide and sphingosine-1-phosphate signaling in embryonic stem cell differentiation.
    Bieberich E
    Methods Mol Biol; 2012; 874():177-92. PubMed ID: 22528448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High levels of sphingolipids in human breast cancer.
    Nagahashi M; Tsuchida J; Moro K; Hasegawa M; Tatsuda K; Woelfel IA; Takabe K; Wakai T
    J Surg Res; 2016 Aug; 204(2):435-444. PubMed ID: 27565080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolomic profiling of sphingolipids in human glioma cell lines by liquid chromatography tandem mass spectrometry.
    Sullards MC; Wang E; Peng Q; Merrill AH
    Cell Mol Biol (Noisy-le-grand); 2003 Jul; 49(5):789-97. PubMed ID: 14528916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of sphingolipids in endothelial barrier function.
    Jernigan PL; Makley AT; Hoehn RS; Edwards MJ; Pritts TA
    Biol Chem; 2015 Jun; 396(6-7):681-91. PubMed ID: 25867999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of sphingosine kinase-1 in cancer: implications for therapeutic targeting.
    Cuvillier O; Ader I; Bouquerel P; Brizuela L; Malavaud B; Mazerolles C; Rischmann P
    Curr Mol Pharmacol; 2010 Jun; 3(2):53-65. PubMed ID: 20302564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Recent advances in study of sphingolipids on liver diseases].
    Wang SY; Zhang JL; Zhang D; Bao XQ; Sun H
    Yao Xue Xue Bao; 2015 Dec; 50(12):1551-8. PubMed ID: 27169276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer treatment strategies targeting sphingolipid metabolism.
    Oskouian B; Saba JD
    Adv Exp Med Biol; 2010; 688():185-205. PubMed ID: 20919655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of sphingosine kinase/S1P axis in ECM remodeling of cardiac cells elicited by relaxin.
    Frati A; Ricci B; Pierucci F; Nistri S; Bani D; Meacci E
    Mol Endocrinol; 2015 Jan; 29(1):53-67. PubMed ID: 25415609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ginsenoside compound K inhibits angiogenesis via regulation of sphingosine kinase-1 in human umbilical vein endothelial cells.
    Shin KO; Seo CH; Cho HH; Oh S; Hong SP; Yoo HS; Hong JT; Oh KW; Lee YM
    Arch Pharm Res; 2014; 37(9):1183-92. PubMed ID: 24687256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The role of sphingolipids in selected cardiovascular diseases].
    Kurek K; Piotrowska DM; Wiesiołek-Kurek P; Chabowska A; Łukaszuk B; Żendzian-Piotrowska M
    Postepy Hig Med Dosw (Online); 2013 Sep; 67():1018-26. PubMed ID: 24088546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.